No Data
Shanghai Sanyou Medical Co., Ltd's (SHSE:688085) Market Cap Dropped CN¥385m Last Week; Individual Investors Bore the Brunt
Shanghai Sanyou Medical Co., Ltd (688085.SH): The Shanghai Stock Exchange's M&A and Restructuring Committee reviewed the asset restructuring matter on December 30.
On December 23, Gelonghui reported that Shanghai Sanyou Medical Co., Ltd (688085.SH) announced that the company plans to acquire a total of 37.1077% equity in Peking Shuimu Tianpeng Medical Technology Co., Ltd (hereinafter referred to as "Shuimu Tianpeng") held by Cao Qun and Xu Nong through the issuance of shares and payment in cash, and 98.9986% limited partner contribution interests in Shanghai Huanzhan Enterprise Management Partnership (Limited Partnership) (hereinafter referred to as "Shanghai Huanzhan") held by 11 transaction parties including Zhan Songtao. This will be done through its subsidiary, Tuoteng (Suzhou) Medical Technology Co., Ltd, which will acquire held by Zhangjiagang Tianpeng Investment Management Co., Ltd in cash.
Shanghai Sanyou Medical Co., Ltd acquires its controlling subsidiary at a 4 times premium, with the necessity of the Trade and performance commitments being key points of inquiry.
① Shanghai Sanyou Medical Co., Ltd intends to acquire the remaining shares of its subsidiary, Shuimu Tianpeng. An assessment indicates that Shuimu Tianpeng's value has increased by 0.693 billion yuan, with a value increase rate of 406.21%. ② Shanghai Sanyou Medical Co., Ltd stated that the acquisition is beneficial for enhancing the company's overall profitability. Prior to the acquisition, Shanghai Sanyou Medical Co., Ltd had consistently faced declining performance.
Shanghai Sanyou Medical Co., Ltd (SHSE:688085) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Shanghai Sanyou Medical Gets Registration Certificate for Ultrasonic Surgery Equipment
Sanyou Healthcare: Third Quarter Report 2024
There Are Reasons To Feel Uneasy About Shanghai Sanyou Medical's (SHSE:688085) Returns On Capital
